Localized amyloidosis of the epididymis: a previously unreported phenomenon
© The Author(s). 2017
Received: 12 April 2017
Accepted: 18 July 2017
Published: 4 August 2017
Localized amyloidosis has not been documented in the epididymis; we report this phenomenon for the first time.
The first aim of this work is to report three cases of localized epididymal amyloidosis. Two cases were clinically detected as epididymal nodules, and a third after reviewing 120 epididymides obtained with neighbouring pathological processes. Amyloid deposits showed Congo red positivity, with yellow-green birefringence, and immunohistochemical expression for light chains kappa and lambda, transthyretin, amyloid P and cytokeratin AE1 AE3. No immunoreactivity for amyloid A was seen. Amyloid deposit location was intraluminal, with partial or total loss of the epididymal epithelium and subsequent passage to the interstitium, forming large masses. No amyloid deposits were observed around blood vessels. A secondary objective was to explore in normal epididymis the amyloid tested in epididymal amyloidosis. In normal epididymides, expression of amyloid P and transthyretin was detected in the apical surface of epithelial cells. Amyloid P also showed strong expression in spermatozoa.
We contribute the existence of localized epididymal amyloidosis, which presents a distinctive, initial intratubular location, where there is a unique proteome and where functional amyloids act during sperm maturation.
In anatomical regions of the male reproductive system that contribute to the transport, maturation and/or required fluid medium of spermatozoa, localized amyloidosis has been pointed out in seminal vesicles, vasa deferentia and ejaculatory ducts [1–9]. The objective of this work is to report localized amyloidosis in the epididymis for the first time. In addition, we study the following: a) amyloid deposit distribution in the epididymis, to assess where the deposits are formed and b) the presence in normal epididymides of the amyloids tested in our cases of epididymal amyloidosis. Our observations indicate that epididymal amyloidosis is organ-limited, with a distinctive initial location (intratubular).
Characteristics of reported cases and antibodies used for immunohistochemistry
Presentation and resulting diagnosis
Larger diameter (cm)
Primary antibodies used
Nodule in the left epididymis
Result: Epididymal amyloidosis
(Free of disease)
Light chain λ
Dako [D: 1:50]
Light chain κ
Dako [D: 1:50]
Dako [D: 1:600]
Abcam [D: 1:50]
Dako [D: 1:50]
CK AE1 AE3
Dako [D: 1:100]
Dako [D: 1:100]
Dako [D: 1:100]
Dako [D: 1:50]
Dako [D: 1:50]
Nodule in the right epididymis
Result: Epididymal amyloidosis
(Free of disease)
Left scrotal swelling for 4 years. Physical examination: a firm, non-reducible mass.
Result: Paratesticular liposarcoma and Epididymal amyloidosis without tumour involvement
(size refers only to epididymal amyloidosis)
Histologic sections were stained with Haemotoxylin and Eosin (H&E), Congo red, Periodic Acid-Schiff (PAS) and Wilder’s reticulin stain. After Congo red staining, the sections were also viewed under polarized light. Immunohistochemical study included the primary antibodies listed in Table 1.
General characteristics of epididymal amyloidosis
In cases 1 and 2 of epididymal amyloidosis, the surgically removed nodules were firm, yellowish grey in colour, and 1.4 and 1.6 cm in size, respectively. Case 3 (obtained after the microscopic review of 120 epididymides) showed a larger diameter of 0.7 cm (Table 1).
Distribution of amyloid deposits
Amyloid deposits were observed in the lumen of the convoluted epididymal tubule and in several lumps in the interstitium (Figs. 1a and 2a to c), showing similar immunohistochemical expression in both locations. On occasion, several separate aggregates of amyloid deposits were organized in a similar convoluted path to that of the epididymis (Fig. 2c).
The distribution and quantity of intratubular amyloid bodies varied depending on the section of the tubule. Thus, they were scarce and free in the lumen of some tubular sections of the epididymis, but numerous in others, where they were densely grouped, obliterating and distending the epididymal lumen (Figs. 1a and 2a to c). The free bodies in the lumen showed Congo red positivity (Fig. 2f), with immunofluorescence under polarized light (Fig. 2g) and amyloid P expression (Fig. 2h), and were associated with other materials, including vesicles, particles, filaments and small dense bodies. Intraluminal CD68+ macrophages (Fig. 2i) were also observed with intracytoplasmic PAS+ granules (Fig. 2j), which expressed transthyretin and amyloid P (Fig. 2k, corresponding to amyloid P).
Relationship between intratubular and interstitial amyloid deposits
Detection of amyloids (with tested expression in epididymal amyloidosis) in normal epididymides
In the epididymides surgically obtained from neighbouring pathologic processes, transthyretin (Fig. 3f) and amyloid P (Fig. 3g) were expressed in the apical surface of the epithelium. Amyloid P also showed strong expression in spermatozoa (Fig. 3g and h). Occasional macrophages with PAS and amyloid P positive bodies were seen.
We report three cases of localized amyloidosis in the epididymis, two clinically detected as a nodular mass and the other obtained together with a neighbouring pathologic process (para-testicular liposarcoma). Although localized amyloidosis has been described in several locations of the male reproductive system, which contribute to the transport, maturation and/or required fluid medium of spermatozoa [1–9], to the best of our knowledge, this is the first description of localized epididymal amyloidosis. Awareness of the existence of epididymal amyloidosis and of its presentation as small nodules in the epididymis, as well as knowledge of its histopathology, is of interest in clinical and pathological differential diagnoses, including tumours. Moreover, the characteristics of the lesion support the initial development of amyloid deposits in the epididymal lumen, where a specific proteome occurs [10–12], and non-pathological functional amyloids and mechanisms of protein aggregation control take place [13–15]. Below, we examine these issues.
Our cases were seen in patients aged 67 and over. Although this type of amyloidosis could be regarded as a senile form, larger series are needed to confirm this possibility.
Our observations indicate an initial deposit of amyloid in the epididymal lumen, with subsequent passage to the interstitium. The findings that support this sequence are as follows: a) densely grouped deposits in some sections of the epididymis occupy both the lumen and the interstitium, after distention of the epididymal lumen and partial epithelial disruption, b) presence of epithelial folds with degenerative phenomena, surrounding portions of intraluminal amyloid deposits, which are partially incorporated in the interstitium, c) epithelial strips remain on the surface of some large interstitial amyloid masses, d) several distinct aggregates of amyloid deposits are organized in a similar convoluted path to that of the epididymis, and e) the deposits occupying both the interstitium and the lumen appear with and without reticulin networks and/or stromal cells, respectively.
Both intraluminal and interstitial deposits in the epididymis show amyloid characteristics, including positivity for Congo red with yellow-green birefringence under polarized light. In our observations, apparent negativity for amyloid A, any evidence of systemic amyloidosis, paraproteinemia or underlying plasma cell dyscrasia, and the absence of amyloid deposits involving vascular walls support an organ-limited deposition of heterogeneous amyloids, including light chains κ and λ, and transthyretin. Amyloid P was also present. However, our immunohistochemical results were obtained in paraffin-embedded tissue blocks, and amyloid deposits can contain several misfolded proteins. Therefore, a more specific characterization of the proteome and misfolded proteins requires further study (see below).
The onset of amyloid deposits in the epididymal lumen may be related to our results showing amyloid P (involved in the deposition, stabilization and persistence of amyloid) and transthyretin (a transport protein in the serum and cerebrospinal fluid) expression in the apical surface of the normal epithelial cells of the epididymis. Moreover, amyloid P showed strong immunoreactivity in the spermatozoa, which concurs with the observations of others authors . Likewise, immunoreactivity for pan CK AE1 AE3 also concurs with the presence of keratins in the sperm proteome .
The comparison with amyloidosis described in other locations of the male reproductive system that contribute to the transport, maturation and/or required fluid medium of spermatozoa, mainly seminal vesicles, indicates that the deposits have a different location: initially intraluminal with subsequent passage to the interstitium in the epididymis, and predominantly sub-epithelial in the seminal vesicles [1–9], as occurs in choroid plexus amyloidogenic papillomas . The mechanisms to explain these differences in the polarization of the deposits require further studies. Likewise, the positive reaction for light-chain antibodies has been reported for several cases of localized amyloidosis in the urogenital tract [19, 20], and the expression of light chains κ and/or λ in localized amyloidosis in other regions is not exceptionally rare .
The unique and distinctive location of amyloid deposits in the epididymal lumen, with subsequent passage to the interstitium, could depend on the peculiar functions of this anatomical region, in which proteomic studies show the more sequentially modified milieu of the body [10–12]. Indeed, the epididymis actively participates in the maturation, protection and acquisition of motility and fertility of spermatozoa by synthesis, secretion and post-transitional modifications of important molecules, including a high concentration of several hundred proteins, most of which are actively secreted by the epididymal epithelium (for review, see ). Spermatozoa are dependent on this extracellular environment, since their DNA is highly compacted, making processes of transcription and translation impossible [22–24]. Epididymosomes (vesicles present in the epididymis) are involved in the acquisition of new sperm proteins during epididymal transit [22–24]. Some of these proteins may form functional amyloids, and in vitro studies have shown amyloid formation in this unique milieu. Thus, this milieu comprises cystatin-related epididymal spermatogenic members (CRES), which pass from monomeric forms in the proximal caput region to an aggregated amyloid state in the distal caput region [15, 25], and amyloidogenic prion protein is present in epididymosomes and associated with hydrophobic proteins in lipophilic complex [26–28]. Likewise, concentration of luminal content occurs in the epididymis (more than 90% of the fluid is removed from the epididymis) , facilitating macromolecular crowding, and protein misfolding and aggregation. However, in the epididymis, amyloids act without causing pathology, due to the mechanisms of extracellular quality control [13, 14, 25]. This control includes: a) ubiquitin-dependent proteolysis (classically considered as an intracellular quality control system and currently as also having extracellular functionality in sperm quality control) , b) chaperones (involved in the prevention of protein aggregation), since chaperone clusterin is found in soluble high molecular mass lipophilic complex present in the lumen of the epididymis during sperm maturation (around 30% of total epididymal secretion ), and c) transglutaminase, which prevents the formation of amyloid-type aggregates of CRES in the epididymis by post-translational modifications (transglutaminase cross-linking of cystatin CRES - ). Therefore, the onset of amyloidosis deposits in the lumen of the epididymis, with subsequent passage to the interstitium, suggests a disturbance of the mechanisms mentioned above, mainly of extracellular (intraluminal) functional amyloid control.
While intracellular, post-translational quality control systems to repair or remove misfolded proteins have been well studied, extracellular mechanisms of folding control of secreted proteins are not well described, except in the lumen of the epididymis [13, 14]. These mechanisms in the epididymis have been considered highly significant for understanding the misfolded protein formation involved in some pathological processes, including Alzheimer’s disease, cerebral angiopathies, and type II diabetes [13, 14]. In this way, amyloid deposits in the epididymis may provide a substrate to explore not only the alteration of the reproductive function, but also the mechanism of extracellular protein misfolding control in several diseases. Thus, new studies in epididymal amyloidosis are required to explore the functional amyloids outlined above and the molecules that act in their extracellular quality control.
We describe the presence of localized amyloidosis in the epididymis for the first time. The initial intraluminal formation is particularly interesting because it may also be the pathological expression of amyloid in an anatomical region with critical functions during sperm maturation, including the uniqueness of the human epididymal proteome and several molecular pathways, such as those involved in specific intraluminal functional amyloids and their quality control.
The authors would like to thank Kim Eddy for the English revision.
There is no any financial support for this work.
Availability of data and materials
Data sharing not applicable to this article as no datasets were generated or analyzed during the current study.
LD-F, RG and MPG participated in the histopathological evaluation, performed the literature review, acquired the photomicrographs and contributed to conception and design. MJG, JLC, LD-F Jr. and HA-A performed the immunohistochemical stain evaluation and revised the manuscript. All the authors read and approved the final manuscript.
Ethics approval and consent to participate
Ethical approval for this study was obtained from Ethical Committee of La Laguna University (No. CEIBA2017-0250).
Consent for publication
Informed consent was obtained from the patients for publication.
The authors declare that they have no competing interests.
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
- Argon A, Sımşır A, Sarsik B, Tuna B, Yörükoğlu K, Nıflıoğlu GG, Sen S. Amyloidosis of seminal vesicles; incidence and pathologic characteristics. Turk Patoloji Derg. 2012;28:44. doi:10.5146/tjpath.2012.01096.PubMedGoogle Scholar
- Coyne JD, Kealy WF. Seminal vesicle amyloidosis: morphological, histochemical and immunohistochemical observations. Histopathology. 1993;22:173.View ArticlePubMedGoogle Scholar
- Furuya S, Masumori N, Furuya R, Tsukamoto T, Isomura H, Tamakawa M. Characterization of localized seminal vesicle amyloidosis causing hemospermia: an analysis using immunohistochemistry and magnetic resonance imaging. J Urol. 2005;173:1273.View ArticlePubMedGoogle Scholar
- Jun SY, Kim KR, Cho KS, Ro JY. Localized amyloidosis of seminal vesicle and vas deferens: report of two cases. J Korean Med Sci. 2003;18:447.View ArticlePubMedPubMed CentralGoogle Scholar
- Kee KH, Lee MJ, Shen SS, Suh JH, Lee OJ, Cho HY, Ayala AG, Ro JY. Amyloidosis of seminal vesicles ejaculatory ducts: a histologic analysis of 21 cases among 447 prostatectomy specimens. Ann Diagn Pathol. 2008;12:235. doi: 10.1016/j.anndiagpath.2007.12.004.
- Pitkänen P, Westermark P, Cornwell GG 3rd, Murdoch W. Amyloid of the seminal vesicles. A distinctive and common localized form of senile amyloidosis. Am J Pathol. 1983;110:64.PubMedPubMed CentralGoogle Scholar
- Seidman JD, Shmookler BM, Connolly B, Lack EE. Localized amyloidosis of seminal vesicles: report of three cases in surgically obtained material. Mod Pathol. 1989;2:671.PubMedGoogle Scholar
- Süess K, Moch H, Epper R, Koller A, Dürmüller U, Mihatsch MJ. Heterogeneity of seminal vesicle amyloid. Immunohistochemical detection of lactoferrin and amyloid of the prealbumin-transthyretin type. Pathologe. 1998;19:115.View ArticlePubMedGoogle Scholar
- Yang Z, Laird A, Monaghan A, Seywright M, Ahmad I, Leung HY. Incidental seminal vesicle amyloidosis observed in diagnostic prostate biopsies--are routine investigations for systemic amyloidosis warranted? Asian J Androl. 2013;15:149. doi:10.1038/aja.2012.125.View ArticlePubMedGoogle Scholar
- Dacheux JL, Belleannée C, Jones R, Labas V, Belghazi M, Guyonnet B, Druart X, Gatti JL, Dacheux F. Mammalian epididymal proteome. Mol Cell Endocrinol. 2009;306:45. doi:10.1016/j.mce.2009.03.007.View ArticlePubMedGoogle Scholar
- Dacheux JL, Dacheux F. New insights into epididymal function in relation to sperm maturation. Reproduction. 2014;147:R27–42. doi:10.1530/REP-13-0420.View ArticlePubMedGoogle Scholar
- Dacheux JL, Dacheux F, Druart X. Epididymal protein markers and fertility. Anim Reprod Sci. 2016;169:76. doi:10.1016/j.anireprosci.2016.02.034.View ArticlePubMedGoogle Scholar
- Cornwall GA, von Horsten HH, Swartz D, Johnson S, Chau K, Whelly S. Extracellular quality control in the epididymis. Asian J Androl. 2007;9:500–7. doi:10.1111/j.1745-7262.2007.00309.x.View ArticlePubMedGoogle Scholar
- Cornwall GA. Role of posttranslational protein modifications in epididymal sperm maturation and extracellular quality control. Adv Exp Med Biol. 2014;759:159. doi:10.1007/978-1-4939-0817-2_8.View ArticlePubMedGoogle Scholar
- Whelly S, Muthusubramanian A, Powell J, Johnson S, Hastert MC, Cornwall GA. Cystatin-related epididymal spermatogenic subgroup members are part of an amyloid matrix and associated with extracellular vesicles in the mouse epididymal lumen. Mol Hum Reprod. 2016;22:729–44. doi:10.1093/molehr/gaw049.View ArticlePubMedGoogle Scholar
- Malm J, Sonesson A, Hellman J, Bjartell A, Frohm B, Hillarp A. The pentraxin serum amyloid P component is found in the male genital tract and attached to spermatozoa. Int J Androl. 2008;31:508. doi:10.1111/j.1365-2605.2007.00800.x.View ArticlePubMedGoogle Scholar
- Skerget S, Rosenow MA, Petritis K, Karr TL. Sperm proteome maturation in the mouse Epididymis. PLoS One. 2015;10(11):e0140650. doi:10.1371/journal.pone.0140650. eCollection 2015View ArticlePubMedPubMed CentralGoogle Scholar
- Díaz-Flores L, Gutiérrez R, Madrid JF, Alvarez-Argüelles H, Valladares F, Spreafico M, Díaz-Flores L Jr. Choroid plexus papilloma with stromal deposition of amyloid and elastic material. Amyloid. 2010;17:69. doi:10.3109/13506129.2010.483117.
- Monge M, Chauveau D, Cordonnier C, Noël LH, Presne C, Makdassi R, Jauréguy M, Lecaque C, Renou M, Grünfeld JP, Choukroun G. Localized amyloidosis of the genitourinary tract: report of 5 new cases and review of the literature. Medicine (Baltimore). 2011;90:212. doi:10.1097/MD.0b013e31821cbdab.View ArticleGoogle Scholar
- Zhou F, Lee P, Zhou M, Melamed J, Deng FM. Primary localized amyloidosis of the urinary tract frequently mimics neoplasia: a clinicopathologic analysis of 11 cases. Am J Clin Exp Urol. 2014;2:71. eCollection 2014PubMedPubMed CentralGoogle Scholar
- Westermark P. Localized AL amyloidosis: a suicidal neoplasm? Ups J Med Sci. 2012;117:244. doi:10.3109/03009734.2012.654861.View ArticlePubMedPubMed CentralGoogle Scholar
- Sullivan R, Frenette G, Girouard J. Epididymosomes are involved in the acquisition of new sperm proteins during epididymal transit. Asian J Androl. 2007;9:483. doi:10.1111/j.1745-7262.2007.00281.x.View ArticlePubMedGoogle Scholar
- Sullivan R, Saez F. Epididymosomes, prostasomes, and liposomes: their roles in mammalian male reproductive physiology. Reproduction. 2013;146:R21–35. doi:10.1530/REP-13-0058.View ArticlePubMedGoogle Scholar
- Sullivan R. Epididymosomes: role of extracellular microvesicles in sperm maturation. Front Biosci (Schol Ed). 2016;8:106–14.View ArticleGoogle Scholar
- von Horsten HH, Johnson SS, SanFrancisco SK, Hastert MC, Whelly SM, Cornwall GA. Oligomerization and transglutaminase cross-linking of the cystatin CRES in the mouse epididymal lumen: potential mechanism of extracellular quality control. J Biol Chem. 2007;282:32912. doi:10.1074/jbc.M703956200.View ArticleGoogle Scholar
- Ecroyd H, Sarradin P, Dacheux JL, Gatti JL. Compartmentalization of prion isoforms within the reproductive tract of the ram. Biol Reprod. 2004;71:993. doi:10.1095/biolreprod.104.029801.View ArticlePubMedGoogle Scholar
- Ecroyd H, Belghazi M, Dacheux JL, Gatti JL. The epididymal soluble prion protein forms a high-molecular-mass complex in association with hydrophobic proteins. Biochem J. 2005;392:211. doi:10.1042/BJ20050459.View ArticlePubMedPubMed CentralGoogle Scholar
- Gatti JL, Métayer S, Moudjou M, Andréoletti O, Lantier F, Dacheux JL, Sarradin P. Prion protein is secreted in soluble forms in the epididymal fluid and proteolytically processed and transported in seminal plasma. Biol Reprod. 2002;67:393.View ArticlePubMedGoogle Scholar
- Mann T, Lutwak-Mann C. Passage of chemicals into human and animal semen: mechanisms and significance. Crit Rev Toxicol. 1982;11:1. doi:10.3109/10408448209089846.View ArticlePubMedGoogle Scholar
- Sutovsky P. Ubiquitin-dependent proteolysis in mammalian spermatogenesis, fertilization, and sperm quality control: killing three birds with one stone. Microsc Res Tech. 2003;61:88. doi:10.1002/jemt.10319.View ArticlePubMedGoogle Scholar